Scientists have found that the "sudden" cardiac death condition related to high-profile deaths or major medical episodes of sports stars including Fabrice Muamba, Christian Erikson and Mark-Vivian Foe, has numerous linked ...
Jul 21, 2026
0
10
A new drug offers hope for people with hypertrophic cardiomyopathy, the world's most common inherited heart disease. The TEMPEST trial, led by University of Manchester researchers, tested the drug—called trientine—in 154 ...
Jul 16, 2026
0
4
A study led by the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), working in collaboration with an international research team, has identified a new molecular mechanism involved in hypertrophic cardiomyopathy, ...
Jul 7, 2026
0
16
A new gene therapy appears to be safe in patients diagnosed with Friedreich ataxia cardiomyopathy, a progressive and fatal inherited cardiac disease, according to a phase 1 clinical trial led by Weill Cornell Medicine researchers. ...
Jun 17, 2026
0
3
Microtubules, part of heart muscle cells' internal "skeleton," help determine how the heart changes shape under stress, and a common signaling pathway called the ERK pathway acts as a key controller of where the building ...
Jun 9, 2026
0
3
The human heart must constantly adapt to changing demands—a task that requires tightly coordinated molecular shuffling in heart cells. One of the key regulators of this process is RBM20, a protein that controls an editing ...
Jun 4, 2026
0
7
Findings from a new study have identified a new model for predicting outcomes for hypertrophic cardiomyopathy (HCM), a heart condition with a prevalence of one in 500 people and a frequent cause of sudden cardiac death. Specifically, ...
May 11, 2026
0
8
Elite footballers of Black ethnicity show important ancestry-related differences in cardiac adaptation. These results were presented at ESC Preventive Cardiology 2026, the annual congress of the European Association of Preventive ...
Apr 24, 2026
0
3
Paula Vanderpluym's smartwatch may look like a small part of her wardrobe, but to a team of researchers in Toronto, it represents something bigger: the potential to proactively care for people living with heart failure. A ...
Apr 9, 2026
0
13
A global clinical trial involving The Hospital for Sick Children (SickKids) has found that mavacamten—a heart medication previously approved for adults—can safely and effectively improve the flow of blood through compromised ...
Mar 30, 2026
0
7
